Want to see SPRY full AI Analyst Report?
ARS Pharmaceuticals (SPRY) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| 0.5 Mg Epinephrine, 1 Mg Epinephrine | Urticaria Chronic | Phase II | Recruiting | An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria | Apr 04, 2025 | ― |
| neffy, Adrenaline | Allergic Reactions | Phase IV | Recruiting | Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy | Feb 18, 2025 | ― |
| Ars-1 | Urticaria | Phase II | Completed | Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares | Apr 27, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| 0.5 Mg Epinephrine, 1 Mg Epinephrine | Phase II | Urticaria Chronic | Recruiting | An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria | Apr 04, 2025 | ― |
| neffy, Adrenaline | Phase IV | Allergic Reactions | Recruiting | Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy | Feb 18, 2025 | ― |
| Ars-1 | Phase II | Urticaria | Completed | Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares | Apr 27, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Ars Pharmaceuticals, Inc. (SPRY) have in its pipeline
ARS Pharmaceuticals SPRY is currently developing the following drugs: 0.5 Mg Epinephrine, 1 Mg Epinephrine, neffy, Adrenaline, Ars-1. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
